Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A Patient”

490 trials

Showing 20 of 490 results

Not applicableStudy completedNCT01579955
What this trial is testing

Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 321
Testing effectiveness (Phase 2)Study completedNCT02002702
What this trial is testing

Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients

Who this might be right for
Acute Heart Failure
Novartis Pharmaceuticals 46
Large-scale testing (Phase 3)Study completedNCT01757405
What this trial is testing

Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 40
Early research (Phase 1)Study completedNCT02920398
What this trial is testing

A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 21
Testing effectiveness (Phase 2)Ended earlyNCT04541628
What this trial is testing

Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A

Who this might be right for
Hemophilia A
Eli Lilly and Company 3
Early research (Phase 1)Active Not RecruitingNCT03818763
What this trial is testing

Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A

Who this might be right for
Hemophilia A
Medical College of Wisconsin 5
Not applicableStudy completedNCT06535971
What this trial is testing

Individualized Exercise Combined With Manual Therapy in Severe Hemophilia Patients With Polyarthropathy

Who this might be right for
Severe Hemophilia
Far Eastern Memorial Hospital 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT06738901
What this trial is testing

An Open-label Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of SKP-0141 for the Treatment and Prophylaxis in Severe Hemophilia a Patients

Who this might be right for
Hemophilia A, Severe
SK Plasma Co., Ltd. 55
Not applicableUnknownNCT01856751
What this trial is testing

Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa

Who this might be right for
Haemophilia
Stowarzyszenie Pomocy Chorym na Zakrzepicę i Skazy Krwotoczne Thrombus 80
Not applicableNot Yet RecruitingNCT07446010
What this trial is testing

Post Approval Observational Study to Learn More About How Safe Octocog Alfa is and How Well it Works in Patients With Severe Hemophilia A in India

Who this might be right for
Hemophilia A
Bayer 33
Not applicableStudy completedNCT03875547
What this trial is testing

Post-marketing Surveillance (Use Result Surveillance) With Refixia®

Who this might be right for
Haemophilia B
Novo Nordisk A/S 28
Large-scale testing (Phase 3)Study completedNCT04323098
What this trial is testing

Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A

Who this might be right for
Hemophilia A
BioMarin Pharmaceutical 22
Large-scale testing (Phase 3)Ended earlyNCT01434511
What this trial is testing

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 1
Large-scale testing (Phase 3)Study completedNCT01913405
What this trial is testing

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

Who this might be right for
Hemophilia A
Baxalta now part of Shire 30
Post-approval studies (Phase 4)Study completedNCT02170402
What this trial is testing

China ADVATE PTP Study

Who this might be right for
Hemophilia A
Baxalta now part of Shire 82
Post-approval studies (Phase 4)Study completedNCT00638001
What this trial is testing

Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy

Who this might be right for
Haemophilia AHaemophilia B
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 70
Not applicableStudy completedNCT03405337
What this trial is testing

Evaluation of Patient and Physician Reported Reasons for Switching Factor VIII Replacement Therapies

Who this might be right for
Hemophilia A
Bayer 160
Not applicableUnknownNCT01623960
What this trial is testing

Quality of Life in Adult Patients With Severe Haemophilia in Turkey

Who this might be right for
Haemophilia
Turkish Society of Hematology 500
Not applicableStudy completedNCT02581969
What this trial is testing

Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."

Who this might be right for
Hemophilia A
Bayer 43
Not applicableStudy completedNCT02941783
What this trial is testing

Drug Use Investigation of Kovaltry in Hemophilia A Patients

Who this might be right for
Hemophilia A
Bayer 230
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation